Secondary Logo

January 2nd, 2016 - Volume 30 - Issue 1
pp: 1-163

First evidence of transmission of an HIV-1 M/O intergroup recombinant virus

Ngoupo, Paul Alain; Sadeuh-Mba, Serge Alain; De Oliveira, Fabienne; More

AIDS. 30(1):1-8, January 2nd, 2016.

The presence of protective cytotoxic T lymphocytes does not correlate with shorter lifespans of productively infected cells in HIV-1 infection

Spits, Hilde B.; Mudrikova, Tania; Schellens, Ingrid M.M.; More

AIDS. 30(1):9-17, January 2nd, 2016.


Preexposure prophylaxis-selected drug resistance decays rapidly after drug cessation

Weis, Julie F.; Baeten, Jared M.; McCoy, Connor O.; More

AIDS. 30(1):31-35, January 2nd, 2016.

Incidence and clearance of anal high-risk human papillomavirus in HIV-positive men who have sex with men: estimates and risk factors

Geskus, Ronald B.; González, Cristina; Torres, Montserrat; More

AIDS. 30(1):37-44, January 2nd, 2016.

A randomized, double-blind, placebo-controlled, short-term monotherapy study of doravirine in treatment-naive HIV-infected individuals

Schürmann, Dirk; Sobotha, Christian; Gilmartin, Jocelyn; More

AIDS. 30(1):57-63, January 2nd, 2016.

Topical cidofovir to treat high-grade anal intraepithelial neoplasia in HIV-infected patients: a pilot clinical trial

Sendagorta, Elena; Bernardino, Jose I.; Álvarez-Gallego, Mario; More

AIDS. 30(1):75-82, January 2nd, 2016.


The effect of HIV infection on anal and penile human papillomavirus incidence and clearance: a cohort study among MSM

Mooij, Sofie H.; van Santen, Daniëla K.; Geskus, Ronald B.; More

AIDS. 30(1):121-132, January 2nd, 2016.

Antiretroviral exposure during pregnancy and adverse outcomes in HIV-exposed uninfected infants and children using a trigger-based design

Williams, Paige L.; Hazra, Rohan; Van Dyke, Russell B.; More

AIDS. 30(1):133-144, January 2nd, 2016.